Cardiovascular disease and diabetes: the vulnerable patientHESS, Katharina; MARX, Nikolaus; LEHRKE, Michael et al.European heart journal supplements. 2012, Vol 14, Num B, issn 1520-765X, B4-B13Article

Beyond glucose: cardiovascular effects of incretins and dipeptidyl peptidase-4 substratesSHANNON, Richard P; ANGELI, Franca S.European heart journal supplements. 2012, Vol 14, Num B, issn 1520-765X, B14-B21Article

Clinical efficacy of aldosterone-blocking agentsBÖHM, Michael; REIL, Jan C; BRAMLAGE, Peter et al.European heart journal supplements. 2011, Vol 13, Num B, issn 1520-765X, B36-B39Article

The heart rate storyCECONI, Claudio; GUARDIGLI, Gabriele; RIZZO, Paola et al.European heart journal supplements. 2011, Vol 13, Num C, issn 1520-765X, C4-C13Conference Paper

Early and aggressive treatment of patients with ST-segment elevation myocardial infarction: deciphering recent clinical trials and the timing of optimal platelet inhibitionVAN 'T HOF, Arnoud W. J.European heart journal supplements. 2010, Vol 12, Num D, issn 1520-765X, D24-D35Article

European Cardiovascular Experts' STEMI (ECES) SummitFERNANDEZ-AVILES, Francisco.European heart journal supplements. 2009, Vol 11, Num C, issn 1520-765X, 39 p.Conference Proceedings

Dual antiplatelet therapy in the drug-eluting stent eraWALLENTIN, Lars.European heart journal supplements. 2008, Vol 10, Num D, issn 1520-765X, D38-D44Article

Long-term treatment strategies for atherothrombotic disease : do platelets define the course?ZIMARINO, Marco; DE CATERINA, Raffaele.European heart journal supplements. 2008, Vol 10, Num I, issn 1520-765X, I8-I13Article

Optimizing platelet inhibitionVAN GIEZEN, J. J. J.European heart journal supplements. 2008, Vol 10, Num D, issn 1520-765X, D23-D29Article

Risk of type 2 diabetes mellitus and coronary heart disease : a pivotal role for metabolic factorsWILSON, Peter W. F; MEIGS, James B.European heart journal supplements. 2008, Vol 10, Num B, issn 1520-765X, B11-B15Article

The place of fondaparinux in the ESC and ACC/AHA guidelines for anticoagulation in patients with non-ST elevation acute coronary syndromesBASSAND, Jean-Pierre.European heart journal supplements. 2008, Vol 10, Num C, issn 1520-765X, C22-C29Article

Heart rate throughout the cardiovascular continuum. Proceedings of a satellite symposium held during the European Society of Cardiology Congress, Munich, Germany, September 1, 2008FERNANDEZ-AVILES, Francisco.European heart journal supplements. 2008, Vol 10, Num F, issn 1520-765X, 23 p.Conference Proceedings

Proceedings from the 4th International Symposium on Stem Cell Therapy and Applied Cardiovascular Biology, Madrid, Spain, 26th and 27th April 2007FERNANDEZ-AVILES, Francisco.European heart journal supplements. 2008, Vol 10, Num K, issn 1520-765X, 45 p.Conference Proceedings

Adjunctive antithrombotic therapy during primary percutaneous coronary interventionDE LUCA, Giuseppe.European heart journal supplements. 2008, Vol 10, Num J, issn 1520-765X, J2-J14Article

Heart rate : from risk marker to risk factorBORER, Jeffrey S.European heart journal supplements. 2008, Vol 10, Num F, issn 1520-765X, F2-F6Conference Paper

Safety and efficacy of intracoronary infusion of mobilized peripheral blood stem cell in patients with myocardial infarction : MAGIC Cell-1 and MAGIC Cell-3-DES-trialsKANG, Hyun-Jae; KIM, Hyo-Soo.European heart journal supplements. 2008, Vol 10, Num K, issn 1520-765X, K39-K43Conference Paper

Differences among GP IIb/IIIa inhibitors : different clinical benefits in non-st-segment elevation acute coronary syndrome percutaneous coronary intervention patientsANTONIUCCI, David.European heart journal supplements. 2007, Vol 9A, issn 1520-765X, A32-A36Article

Antihypertensive drugs: a perspective on the value of improved blood pressure control in the USALONG, Genia; CUTLER, David M; BERNDT, Ernst R et al.European heart journal supplements. 2007, Vol 9B, issn 1520-765X, B19-B22Conference Paper

Blood pressure is the most important cause of death and disability in the worldHE, Feng J; MACGREGOR, Graham A.European heart journal supplements. 2007, Vol 9B, issn 1520-765X, B23-B28Conference Paper

Adherence: a major unmet need. CV Success Zone programmeGLASSPOOL, John.European heart journal supplements. 2007, Vol 9B, issn 1520-765X, B37-B41Conference Paper

Dual antiplatelet therapy in high-risk patientsVAN DE WERF, Frans.European heart journal supplements. 2007, Vol 9D, issn 1520-765X, D3-D9Article

History of electrical therapy for the heartSUTTON, Richard; FISHER, John D; LINDE, Cecilia et al.European heart journal supplements. 2007, Vol 9I, issn 1520-765X, I3-I10Article

Evolution of pacing for bradycardias : sensorsLAU, Chu-Pak; TSE, Hung-Fat; CAMM, A. John et al.European heart journal supplements. 2007, Vol 9I, issn 1520-765X, I11-I22Article

Non-fluoroscopic mapping as a guide for atrial ablation : current status and expectations for the futurePAPPONE, Carlo; SANTINELLI, Vincenzo.European heart journal supplements. 2007, Vol 9I, issn 1520-765X, I136-I147Article

The late sodium current: emerging involvement in cardiovascular disease and role as a target for potential new therapies in anginaPOOLE-WILSON, P. A; TAVAZZI, L.European heart journal supplements. 2006, Vol 8, Num A, issn 1520-765X, 27 p.Conference Proceedings